Top Banner

of 31

WHS PR Symposium: Obesity and Cancer The Next Frontier

Jun 02, 2018

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    1/31

    Edna M. Mora, MD,Professor, Department of Surgery, School of Medici

    Medical Sciences Campus, University of Puerto Rico Investigator UPR Comprehensive Cancer C

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    2/31

    I, or my immediate family member includingspouse/partner, have at present and/or havehad within the last 12 months, or anticipateNO financial interest/arrangement oraffiliation with one or more organizationsthat could perceived as a real or apparentconflict of interest in context to the design,implementation, presentation, evaluationetc. of this presentation .

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    3/31

    True or False

    ______ 1. Obesity is not a disease, but a judgement of weight bysociety.

    ______ 2. Obesity promotes cancer.

    ______ 3. Obesity induces cancer.

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    4/31

    Is obesity important in the cancer field?

    Obesity and its relationship to cancer physiology and biologyDoes obesity promote a cancer-promoting environment(carcinogenesis)?Does obesity increase the growth and metastatic potential oftumors? (tumorogenesis)How to manage obesity in the cancer patient receivingtreatment or after treatment?Obesity definitionConclusions

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    5/31

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    6/31

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    7/31

    In the US, 33% of adults and 17% of children and adolescents

    are categorized as obese.In Puerto Rico, 32% overweight, 17% obese (children) 2012

    66% overweight, 25-30% obese (adult)2011Body mass index (BMI)- WHO categories25-29.9 kg/m2- overweight30 kg/m2- obesityObesity contributes to several major illnesses: cardiovascular,diabetes, cancer. It increases the risk and mortality for all ofthem.

    Ligibel, JA, et al. Journal of Clinical Oncology 32

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    8/31

    Obesity increased cancer risk, recurrence and cancer-related

    mortality in patients with early-stage cancer.Breast cancer- obese at the time of diagnosis

    75% increased in mortality in pre-menopausal women34% increased in mortality in post-menopausal women

    Prostate cancer- obese menincrease risk of developing biologically aggressive prostatecancer and more likely to have advanced disease at the timeof diagnosis

    Ligibel, JA, et al. Journal of Clinical Oncology 32: 1Boeing H, et al Best Prac Res Clin Endo Meta 27:21

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    9/31

    A BMI 35 kg/m2 may be associated with an increased risk of colocancer recurrence and mortality, but data is less consistent.Endometrial cancer- risk increased linearly with increasing BMI. It mainly driven by general fatness attained at late adulthood.Evidence for a relationship of fatness at diagnosis and survival isweak.Renal cell cancer- there are uncertainties regarding gender andobesity effect on survival.Esophageal cancer- risk driven by abdominal fat. No relationshipwith survival.

    Ligibel, JA, et al. Journal of Clinical Oncology 32: 1Boeing H, et al Best Prac Res Clin Endo Meta 27:21

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    10/31

    Other cancers related to obesity:

    uterinepancreaticthyroidgallbladder

    ovarian Non-Hodking lymphomacervical Multiple Myelomaliver

    Ligibel, JA, et al. Journal of Clinical Oncology 32: 1Boeing H, et al Best Prac Res Clin Endo Meta 27:21

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    11/31

    Cancer survivors are NO more likely to beconsuming a healthy diet, exercising, ormaintaining a healthy weight compared toadults without history of cancer.

    Ligibel, JA, et al. Journal of Clinical Oncology 32: 1-7, 2014

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    12/31

    Ligibel, JA, et al. Journal of Clinical Oncology 32: 1-7, 2014

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    13/31

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    14/31

    Carcinogenesis Tumorogenesis Metastatses

    http://www.google.com.pr/url?sa=i&rct=j&q=&esrc=s&source=images&cd=&cad=rja&uact=8&ved=0CAcQjRw&url=http://www.belleonline.com/newsletters/volume9/vol9-1/n2v91.html&ei=DSJiVMbEEYejgwS204LAAg&bvm=bv.79189006,d.eXY&psig=AFQjCNHSwB1O60b8d66dERacd0KVa4g_7Q&ust=1415803682834623
  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    15/31

    Adipose tissue is a very active endocrine and metabolic organ.Cells adipocytes

    pre-adipocytesfibroblastsmacrophagesblood vessels

    Adipokines (cytokines)leptin

    adiponectinplaminogen activator inhibitor (PAI)-1VEGFTNF- IL-6

    Inflammatory m

    Van Kruijsdijk RCM, et al. Ca Epi Bio Prev 18: 2569-2578

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    16/31

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    17/31

    Immune System

    Macrophages- M1 (increased), M2 (deceased)EosinophilsNeutrophilsMast cells

    T-lymphocytesB-Lymphocytes

    INFLAMMATION

    Catalan V et al. Frontiers in Physiology 4(275)

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    18/31

    Catalan V et al. Frontiers in Physiology 4(275): 1

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    19/31

    Perez-Hernandez AI, et al. Frontiers in Endocrinol 5(65): 1

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    20/31

    Van Kruijsdijk RCM, et al. Ca Epi Bio Prev 18: 2569-

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    21/31

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    22/31

    Education

    Exercise programHealthy nutrition interventionwith follow-upSet goalsInvolve the relatives

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    23/31

    Oprah Magazine March 2014

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    24/31

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    25/31

    Ligibel, JA, et al. Journal of Clinical Oncology 32

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    26/31

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    27/31

    Ashwell M, et al. BMC Medicine 12:207, 201

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    28/31

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    29/31

    Obesity is an important aspect of cancer.

    Obesity increases the risk of several types of cancers andincreases the progression and survival of the disease.Obesity acts as a carcinogenic, tumorogenic and metastaticenvironment. WHt ratio is more practical and functional than BMI in

    associating obesity with risk of diseases.We should start implementing educational strategies todecrease obesity and overweight in children and adults.

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    30/31

    True or False

    ______ 1. Obesity is not a disease, but a judgement of weight bysociety.

    ______ 2. Obesity promotes cancer.

    ______ 3. Obesity induces cancer.

  • 8/10/2019 WHS PR Symposium: Obesity and Cancer The Next Frontier

    31/31